Announcements Trials
Browse Landscape

Phase

Phase 2 146Phase 3 125Phase 1/2 43Phase 1 43Phase 2/3 10Phase NA 6Phase 4 2

Status

Recruiting 4Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Thoracic 3Genitourinary 2Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Prostatic Neoplasms 1Pathological and Imaging Examinations Confirmed Metastatic Prostate Cancer 1NSCLC 1Lung Neoplasms 1Hypopharyngeal Neoplasms 1

Interventions

Standard of Care 172Blood Specimen Collection 133Exercise 121Educational Status 113Methods 107Surveys and Questionnaires 104Practice Guidelines as Topic 104Interviews as Topic 103Early Intervention, Educational 92Magnetic Resonance Spectroscopy 79Specimen Handling 74Radiosurgery 67Radiotherapy 56Palliative Care 48Biopsy 40Patient Navigation 37Control Groups 35Drug Therapy 32Therapeutics 31Resistance Training 31Surgical Procedures, Operative 30Diet Therapy 30Behavior Therapy 29Counseling 28Proton Therapy 25Acupuncture Therapy 25Exercise Test 24Nutrition Assessment 23Magnetic Resonance Imaging 23Radiation 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase NA × Docetaxel × 1 year × Clear all
NCT00883480 2026-04-28

SLAT

Spanish Lung Cancer Group

Phase NA Completed
153 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06484491 2026-01-30

HyDose

University Medical Center Groningen

Phase NA Recruiting
87 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06576635 2026-01-20

LUNG-05

University of Illinois at Chicago

Phase NA Recruiting
29 enrolled
Thoracic

NSCLC

NCT05494190 2025-12-30

The Management of Metastatic Neck Nodes in N2/3 Hypopharyngeal Squamous Cell Carcinoma

Eye & ENT Hospital of Fudan University

Phase NA Recruiting
111 enrolled
Head & Neck

Hypopharyngeal Neoplasms

NCT07172685 2025-09-15

Study on Triple Therapy Combined With HIFU for High-Tumor-Burden mHSPC

Qilu Hospital of Shandong University

Phase NA Recruiting
116 enrolled
Genitourinary

Prostatic Neoplasms

NCT07112209 2025-08-08

Clinical Study of Rezvilutamide Combined With Docetaxel Chemotherapy in the Treatment of Abiraterone-Resistant Prostate Cancer

Zhujiang Hospital

Phase NA Enrolling by invitation
20 enrolled
Genitourinary

Pathological and Imaging Examinations Confirmed Metastatic Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡